005250.KO Green Cross

Healthcare Biotechnology Korea Stock Exchange
9,742 KRW
Close of Nov 5, 2026
8,630 18,010
Market cap
KRW 438B
P/E
-
P/B
0.50x
ROE
-3.6%
Dividend yield
7.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 005250.KO undervalued?

Graham number

The Graham number of Green Cross cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Green Cross fundamental analysis

No fundamental analysis for Green Cross yet.

Green Cross stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Green Cross

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purp…

Full company profile